Tetanus cost-effectiveness of therapy

Jump to navigation Jump to search

Tetanus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tetanus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Xray

CT scan

MRI

Ultrasound

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tetanus cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tetanus cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tetanus cost-effectiveness of therapy

CDC on Tetanus cost-effectiveness of therapy

Tetanus cost-effectiveness of therapy in the news

Blogs on Tetanus cost-effectiveness of therapy

Directions to Hospitals Treating Tetanus

Risk calculators and risk factors for Tetanus cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Michael Maddaleni, B.S.

Overview

The major cost encountered with tetanus is in the form of the vaccine. There are many different trade names associated with the tetanus vaccine that come with slightly different costs. The prices of the vaccines are all listed in the following tables. The tables are separated based upon pediatric doses versus adult doses. The DTaP vaccine that is mentioned in the passage stands for Diptheria, Tetanus, and Pertussis.

Cost-Effectiveness of Therapy

Pediatric vaccine

Adult vaccine

References

Template:WH Template:WS